FSA Analysis

Data | 8 Nov 18

Investors had no place to go but down in October. Which China funds fared the best and worst?

Asset Class in Focus | 23 Oct 18

In the next 12 months, research suggests that allocations to China equity funds will be up while US and European equity product exposure will decrease, according to data collected by FSA.

Asset Class in Focus | 6 Jun 18

Ten years after the global financial crisis of 2008, FSA notes that pharmaceutical, healthcare and biotech stocks weathered that year better than other sectors.

Asset Class in Focus | 31 May 18

Riding China’s policy bus is not as easy as it sounds, as the poor performance of China policy-driven funds shows.

Asset Class in Focus | 22 Sep 17

Part two of a look at the hype surrounding the ESG theme finds that there are sound reasons to be skeptical about claims that ESG investments outperform the general market.

FSA Analysis | 30 Aug 17

As capital pours into green-themed funds, nobody is questioning why a growing list of ESG ‘champions’ are under investigation for involvement in a massive, multi-year environmental scandal.

FSA Analysis | 3 Nov 16

As the British government struggles to trigger an exit from the European Union, fund distribution heads at some of the biggest names in the industry share their thoughts on the implications for their UK and European operations.

Data | 4 Mar 16

How many top quartile equity funds in Asia remain there after three years? FE Advisory has crunched the numbers.

FSA Analysis | 24 Feb 16

Market volatility in the five vulnerable economies was muted during December, when US interest rates were raised.

FSA Analysis | 21 Jan 16

Funds that claim to mitigate volatility have been put to the test over the last six tumultuous months. Which ones have actually navigated well?